These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 9866930
21. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087 [Abstract] [Full Text] [Related]
22. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Al-Marri MR. Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769 [Abstract] [Full Text] [Related]
23. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis. Törün T, Tahaoğlu K, Ozmen I, Sevim T, Ataç G, Kir A, Güngör G, Bölükbaşi Y, Maden E. Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975 [Abstract] [Full Text] [Related]
24. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis]. Chen QL, Chen L, Yin JJ. Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519 [Abstract] [Full Text] [Related]
25. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis]. Yoshiyama T, Ito K, Ogata H, Aono A, Wada M. Kekkaku; 2005 Jan; 80(1):9-14. PubMed ID: 15839057 [Abstract] [Full Text] [Related]
26. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic. Kim HJ, Hong YP, Kim SJ, Lew WJ, Lee EG. Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771 [Abstract] [Full Text] [Related]
27. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients. Prasad R, Verma SK, Sahai S, Kumar S, Jain A. Indian J Chest Dis Allied Sci; 2006 Dec; 48(3):183-6. PubMed ID: 18610675 [Abstract] [Full Text] [Related]
28. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism]. Mizutani H, Horiba M, Shindoh J, Kimura T, Son M, Wakahara K. Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388 [Abstract] [Full Text] [Related]
29. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999. Crudu V, Arnadottir T, Laticevschi D. Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338 [Abstract] [Full Text] [Related]
31. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis. Park SK, Lee CM, Heu JP, Song SD. Int J Tuberc Lung Dis; 2002 Feb; 6(2):143-9. PubMed ID: 11931413 [Abstract] [Full Text] [Related]
32. [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan]. Sato K, Nagai H, Kurashima A, Mori M, Katayama T. Kekkaku; 1995 Oct; 70(10):585-9. PubMed ID: 8523851 [Abstract] [Full Text] [Related]
33. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis]. Kobashi Y, Okimoto N, Matsushima T, Abe T, Nishimura K, Shishido S, Kawahara S, Shigeto E, Takeyama H, Kuraoka T. Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137 [Abstract] [Full Text] [Related]
34. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance]. Mishin VIu, Chukanov VI, Vasil'eva IA. Probl Tuberk; 2002 Dec; (12):18-23. PubMed ID: 12611329 [Abstract] [Full Text] [Related]
35. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains]. Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB. Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654 [Abstract] [Full Text] [Related]
36. [Miss-management in treatment failure of pulmonary tuberculosis]. Ito K, Yoshiyama T, Wada M, Ogata H. Kekkaku; 2004 Oct; 79(10):561-7. PubMed ID: 15631107 [Abstract] [Full Text] [Related]
37. [Current situation of contacts examination and chemoprophylaxis for persons exposed to multi-drug resistant tuberculosis in ordinance-designated cities in Japan]. Sasaki Y, Yamagishi F, Yagi T. Kekkaku; 2005 Oct; 80(10):637-42. PubMed ID: 16296391 [Abstract] [Full Text] [Related]
38. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK, Kim JH, Kang H, Cho JS, Smego RA. Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [Abstract] [Full Text] [Related]
39. [Multiresistant tuberculosis in the Zurich Höhenklinik Wald from 1984 to 1992]. Linnenberg HS, Pfyffer GE, Brändli O. Schweiz Rundsch Med Prax; 1993 Oct 05; 82(40):1096-100. PubMed ID: 8210878 [Abstract] [Full Text] [Related]
40. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Kam KM, Yip CW. Int J Tuberc Lung Dis; 2001 Sep 05; 5(9):815-23. PubMed ID: 11573892 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]